SE 2011, 'Expanding the chiral pool: oxidation of meta-bromobenzoic acid by R. eutrophus B9 allows access to new reaction manifolds', Expanding the chiral pool: oxidation of meta-bromobenzoic acid by R. eutrophus B9 allows access to new reaction manifolds.
Introduction
The dearomatising dihydroxylation of an aromatic substrate by a microorganism was first reported by Gibson over 40 years ago. 1 It was subsequently recognised that the resultant 15 diene diols were useful starting materials for synthesis owing to their densely-packed, differentiated functionality. Indeed, their synthetic value is enhanced further by the fact that substituted arenes give rise to enantiopure diols in most instances. The production and utilisation of these arene- 20 derived diols has become established methodology and the field has been the subject of several excellent reviews. 2 Thus far, over 400 arene cis-diol products have been reported. The vast majority of these are produced by organisms expressing toluene dioxygenase (TDO), 25 naphthalene dioxygenase (NDO) and biphenyl dioxygenase (BPDO) enzymes. These metabolise substituted arene substrates in a regio-and stereoselective fashion. A reliable predictive model has been reported for such transformations 3 and the sense of enantioinduction is conserved across 30 organisms and substrates (Scheme 1a, ortho-meta oxygenation). In contrast, organisms expressing benzoate dioxygenase (BZDO) enzymes oxidise benzoic acids in a process that exhibits not only different regioselectivity, but also the opposite sense of enantioinduction. For example, R. 35 eutrophus B9, 4 P. putida U103 5 and P. putida KTSY01 (pSYM01) 6 oxidise benzoic acid to benzoate 1,2-cis dihydrodiol 4 (Scheme 1b, ipso-ortho oxygenation).
Scheme 1 Regio-and stereoselectivity of dioxygenases. 40 Diol acid 4 has seen several diverse applications in organic synthesis to date. In 1995, Widdowson et al. reported the production of 4 with P. putida U103. 7 The absolute stereochemistry of 4 was determined by means of X-ray crystallographic analysis of a para-bromobenzoyl derivative. 45 The ability of derivatives of 4 to participate in [4+2] cycloadditions with various dienophiles was also demonstrated. In 2001, Myers et al. described multiple approaches for elaborating 4, demonstrating that each position on the ring could be functionalised in a selective fashion 50 through judicious choice of reaction sequence. 8 They also described in detail a large-scale preparation of 4. That the derivatives described therein are of synthetic utility was first shown by the report in 2004 of the synthesis of carbocyclic analogues of topiramate. 9 In this work, Parker et al. described 55 a route to analogues of this anticonvulsant agent, requiring between 3 and 4 steps from one of Myers' chirons; the authors also describe the first use of 4 to access a carbohydrate target, carba-β-L-fructopyranose. Also in 2004, Mihovilovic et al. reported intramolecular Diels-Alder reactions of derivatives 60 of 4 bearing tethered dienophiles. 10 In 2005, Myers et al. disclosed the total synthesis of natural and unnatural tetracycline antibiotics 11 via a synthetic sequence commencing from a derivative of 4 they had described four years previously. 8 It is noteworthy that whilst the first stereocentre in the target tetracyclines was set in the arene dihydroxylation step, all subsequent stereocentres were installed under substrate control; all stereochemical information in the final products is thus of ultimate enzymatic origin. In 2010, the Mihovilovic group published a full 70 paper 12 on intramolecular Diels-Alder reactions with 4 and, most recently, the chemistry of 4 has been augmented by our report that simple derivatives of 4 are amenable to complexation to form tricarbonyliron(0)diene complexes. 13 We have been able to demonstrate that such complexation 75 permits the synthesis of otherwise inaccessible moieties. Most notably a diene possessing the ortho,meta pattern of oxygenation found in 2 but antipodal to 2 may be accessed from 4 by means of such organoiron complexes. 14 The unique synthetic versatility of 4 has thus been 80 demonstrated. However, we sought to enhance further the utility of the BZDO-mediated benzoate dihydroxylation by use of substituted benzoate substrates. The viability of metabolising substituted benzoates by this approach has been established previously. Studies on Ralstonia eutrophus B9 † 85 have shown that a variety of mono-and disubstituted benzoates are acceptable substrates. It was noted that turnover rates decreased in accordance with the steric demand of a substituent, with the ortho position being least tolerant of substitution (only ortho-fluorobenzoate underwent dioxygenation) and the meta position being the most tolerant. 4, 15 Many other organisms expressing BZDOs have 5 been evaluated for their ability to process substituted benzoates, 16 as have organisms expressing TADO 17 (toluate dioxygenase), TERDOS 18 (terephthalate dioxygenase), IPADO 19 (isophthalate dioxygenase). To our knowledge, however, there is just one example to date of the use in 10 synthesis of an arene dihydrodiol derived from a substituted benzoate: Banwell's use of a metabolite derived from metaethyltoluene in an approach to vinblastine 20 (Scheme 2). Scheme 2 Banwell's access to arene diol 7 via meta-ethylbenzoic acid. 15 In the present study, we opted to exploit arene diols derived from the metabolism of meta-bromobenzoic acid by R. eutrophus B9 (Scheme 3). We anticipated a twofold effect due to incorporation of a bromine in the products. Firstly, this halide would modulate the electron density of the diene such 20 that it would exhibit reactivities distinct from those of the parent system 4. Secondly, a bromodiene would be amenable to diverse cross-coupling reactions to permit further functionalization in a manner that would not be possible for unsubstituted diene 4. As is the case for any meta-substituted benzoate, metabolism of 8 may give rise to two regioisomeric diols, 9 and 10, reflecting the possibility of the substrate being accommodated 30 in two possible orientations in the BZDO active site. In the specific case of substrate 8, literature precedent was ambiguous. In their original report on R. eutrophus B9, 4 Reiner and Hegeman describe the isolation of both 3-and 5substituted arene diols from the metabolism of meta- 35 substituted benzoates, but product ratios were not quantified. Subsequently, Knackmuss and Reineke quantified product formation and found that 5-substituted diols analogous to 10 were formed more rapidly than the corresponding 3substituted regioisomers analogous to 9. 15a In both of the 40 above studies, however, only meta-chloro-and meta-methyl benzoate were employed as substrates, not metabromobenzoate 8. Reineke and co-workers' subsequent study 15c has been the only one thus far to specifically address the metabolism of meta-bromobenzoate 8 by R. eutrophus B9. 45 Whilst the production of both 9 and 10 is described, the product ratio was not determined. In this same study, it is stated that when using meta-methylbenzoate, the 5-methyl analogue of 10 is "accessible only with difficulty", whereas the 3-methyl analogue of 9 is "isolable in good yield"; such 50 statements seem to contradict the earlier study. 15a Thus, it was unclear at the outset what the regiochemical outcome of metabolism of 8 by R. eutrophus B9 would be.
Results and Discussion
We undertook the biooxidation of 8 in accordance with the 55 procedure of Myers et al., 8 but on a 15 L scale. R. eutrophus B9 cells were induced with a small quantity of benzoate before addition of sodium meta-bromobenzoate solution portionwise over 48 h; disodium succinate solution was added as sole carbon source. The fermentation broth was then 60 centrifuged to remove cellular material and the supernatant was concentrated under reduced pressure. The concentrate was acidified to pH 3.0 and extracted numerous times with ethyl acetate. Organic washings were dried, then concentrated under reduced pressure to give a crude mixture of 8, 9 and 10. 65 NMR analysis indicated that unreacted 8 was the major constituent of the crude mixture. meta-Bromobenzoate 8 had been introduced to the fermentation vessel at a rate comparable to that used previously 8 in the non-halogenated case, but R. eutrophus B9 metabolised the brominated 70 substrate much more slowly, as expected, leading to accumulation of unreacted 8. Formation of 3-bromo product 9 was found to have predominated (>10:1) over the 5-bromo isomer 10.
Purification of this crude material was effected by repeated 75 trituration with dichloromethane; this served to remove both the starting material 8 and also the traces of 5-bromo product 10. After 7 triturations, NMR analysis showed the residual quantity of 8 to be negligible. By this means, pure 3-bromo product 9 was obtained in a yield of 65 mg per litre of 80 fermentation broth, approximately two orders of magnitude lower than those reported for the unsubstituted benzoate. 8 With access to 9 secured we sought to verify the absolute stereochemistry through X-ray analysis of a crystalline derivative. The configuration of 4 was originally determined 85 by Widdowson et al. through formation of the corresponding para-bromobenzoylmethyl ester and subsequent X-ray analysis; 7 the same approach was adopted to determine the configuration of 7. 20 However, as 9 already incorporates a heavy atom, we opted instead to target a crystalline Single crystals of 13 suitable for X-ray structure determination were obtained from diffusion of petroleum ether into a solution of 13 in ethyl acetate. The structure of 13 is depicted in Figure 1 and confirms the absolute stereochemistry as (1S,2S). Thus, the sense of 5 enantioinduction in the formation of 9 is the same as in the formation of 4 and 7, as expected. probability. H atoms are shown as spheres of arbitrary radius. 10 That the sole cycloadduct formed (13) is that in which the dienophile approaches anti to the acetonide is in keeping with Widdowson's precedent. 7 Aside from that report, all literature examples of heterodienophile cycloadditions with arene diol derived acetonides involve substrates with the ortho-meta 15 pattern of oxygenation (c.f. 2). Here also, every report describes dienophile addition anti to the acetonide. 22, 23 In such substrates the original arene substituent is attached to the diene. In contrast, in 12 (which has the ipso-ortho pattern of oxygenation, c.f. 4), the original arene substituent is attached 20 to an sp 3 centre and will not be coplanar with the diene. If the substituent is of sufficient steric bulk, approach of the dienophile to both diene faces may be hindered. Exclusive formation of 13 in this instance is indicative of the steric bulk of the acetonide being the controlling factor in determining 25 regioselectivity of cycloaddition, not steric bulk of the ester. The above considerations are also relevant in the context of Diels-Alder dimerisation. Arene diol derived acetonides with the ortho-meta pattern of oxygenation (c.f. 2) are known to undergo spontaneous dimerization in many instances; this has 30 been reported with halodienes, e.g. R = Br, 23j,24a-c Cl 23j,24b,c and also with many other substituents on the diene (R = CF 3 , 23b,j,24c R = C 2 H 3 , 23j,24c,d R = CN, 24e R = COOMe, 24f R = COOEt, 23w R = COOCH 2 CCH, 23w R = SiMe 2 H, 24g,h R = SiMe 2 C 2 H 3 24g,h and R = Me 24i ). In each instance, the 35 dimerisation is reportedly totally selective for formation of the adduct which is anti both with respect to the diene and also the dienophile. (The only reported exception to this trend is dimerisation of the acetonide of the parent unsubstituted diene 2, R = H 25a minor cycloadduct deriving from syn diene 40 addition and anti dienophile addition has also been reported 22, 26 ). The behaviour of the bromodiene acetonide 12 reported here is in marked contrast to the above cases, in that we have observed no dimerisation of 12 upon prolonged storage at room temperature or below. Dimerisation of the 45 non-brominated analogue of 12 has also not been reported. We ascribe this inertness to dimerisation to the fact that such acetonides with the ipso-ortho pattern of oxygenation (c.f. 4) present sterically demanding substituents on both sides of the diene, hence retarding the formation of all possible isomeric 50 dimers. We next examined the susceptibility of the bromodiene to oxidative elaboration. Neither 11 nor 12 gave tractable products upon attempted epoxidation with mCPBA, in contrast to the corresponding non-halogenated dienes. 8 55 However, osmium tetroxide-mediated dihydroxylation of 12 proceeded smoothly to afford diol 14 as the sole regio-and diastereoisomer (Scheme 5). Such selectivity is also in contrast to the non-halogenated series, wherein the corresponding diene 15 undergoes dihydroxylation to afford a 60 5:1 mixture of regioisomers favouring the other olefin. 8 The installation of the free diol functionality in 14 on the β-face was confirmed by NOESY NMR experiments. ‡ Reductive elaboration of bromodiene 12 also proceeded in a markedly different fashion to the non-halogenated analogue 15.
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Whereas LiAlH 4 -mediated reduction of the ester in 15 to give 16 is reportedly 7, 10, 12 high-yielding (Scheme 6a), the corresponding reduction of bromodiene 12 affords the primary alcohol 17 in only 11% yield. We ascribe this low yield partly to the concomitant formation of appreciable amounts of 70 debrominated product 16, which we have isolated (Scheme 6b). The complexation of arene diols of type 2 with a tricarbonyliron fragment has been extensively studied. 27 We have reported previously 13 on complexation of 18 (the methyl 80 ester of 4) to afford 19 as the sole product, with iron complexed to the α-face (Scheme 7a). A later attempt 14 to reverse the facial selectivity in this complexation by use of an acetonide 15 to block the α-face did indeed result in complexation of iron to the diene β-face, but the isolated 85 product (20) was that in which acetonide migration had occurred (Scheme 7b). We were therefore keen to determine the outcome of complexation of bromodiene acetonide 12 as an iron carbonyl in order to shed light on the mechanism of formation of 20. In the event, treatment of 12 with 90 nonacarbonyldiiron in THF afforded isomeric complexes 21 and 22, in which 21 was the major isomer (Scheme 7c). The structure of 21 was determined unambiguously by X-ray crystallography (Figure 2 ). (The minor isomer 22, which was appreciably less stable than 21, could not be crystallised successfully; its structure was assigned by 2D NMR experiments ‡ and by comparison with 21.) In this instance, the 5 sole products are those in which acetonide migration has not occurred. This may be explained by the fact that in 12, the carbon to which an acetonide oxygen would be bonded upon rearrangement already bears the bromine substituent. We had previously concluded that the formation of 20 arose via 10 "clockwise" migration of the acetonide, rather than "anticlockwise" migration of the ester. 14 The above transformations of bromodiene 12 represent cases in which the presence of the halogen modulates the reactivity of the system with respect to the unsubstituted diene case. However, we wished to exploit further the value inherent in the bromine substituent by using transformations that would 30 not be possible for the unsubstituted case. A dienyl bromide is suggestive of applications in cross-coupling chemistry and in the more common ortho,meta arene dihydrodiol series, both 2 (R = Br) 24a,28 and 2 (R = I) 28a,h,n,29 have indeed been exploited in this context. To date, such cross-couplings have not been 35 reported for derivatives of 4.
We first examined a Suzuki-Miyaura coupling 30 of protected bromodiene 12 with para-tolylboronic acid. Union of these fragments under palladium catalysis was indeed achieved, although it was found that the reaction conditions 40 also effected ester hydrolysis. The free acid 23, recovered from the aqueous phase, was re-subjected to esterification with (trimethylsilyl)diazomethane to afford the originally targeted methyl ester 24, albeit in moderate yield (Scheme 8). A much more straightforward cross-coupling was the 45 Sonogashira 31 reaction of 12 with (triisopropylsilyl)acetylene, which afforded the dienyne 25 in near-quantitative yield (Scheme 8).
Scheme 8
Cross-couplings of the bromodiene. 50 Dienyne 25 is a useful intermediate for further functionalization. Desilylation with TBAF affords terminal acetylene 26, which is amenable to the Huisgen 32 coppercatalysed azide-alkyne cycloaddition protocol. We have demonstrated this through the reaction of 26 with benzyl azide 55 to afford triazole 27 (Scheme 9). Scheme 9 Azide-alkyne "click" cycloaddition.
Conclusions
We have demonstrated the versatility of a halobenzoate- 60 derived ipso,ortho-oxygenated arene dihydrodiol in various synthetic contexts and shown that the presence of the halogen fundamentally alters the course of the reaction in many instances. The formation of cross-coupling products 23-27 is especially significant, as these structures are arene 65 dihydrodiol derivatives that would not be accessible by direct metabolism of the corresponding arene precursors. Thus, for example, accessing 23 by biotransformation of biaryl carboxylic acid 28 would not be expected to succeed as the steric bulk of the tolyl substituent would likely preclude docking of 28 in the R. eutrophus B9 BZDO active site. Compound 23 is nevertheless accessible, by means of the 5 indirect route described in this work (Scheme 10).
Scheme 10
Current efforts in our laboratory are focused on optimising the production process for 9 and incorporating this versatile 10 chiron in the synthesis of more complex targets, including appropriate natural products. The results of these endeavours will be reported subsequently.
Experimental
General 15 Reactions which required the use of anhydrous, inert atmosphere techniques were carried out under an atmosphere of nitrogen. Nonacarbonyldiiron was dispensed in a glovebox. Solvents were dried and degassed by passing through anhydrous alumina columns using an Innovative Technology 20 Inc. PS-400-7 solvent purification system. Petrol refers to petroleum ether, bp 40-60 °C. TLCs were performed using aluminium-backed plates precoated with Alugram ® SIL G/UV and visualized by UV light (254 nm) and/or KMnO 4 followed by gentle warming. Flash column chromatography was carried 25 out using Davisil LC 60Å silica gel (35-70 micron) purchased from Fisher Scientifics. IR spectra were recorded on Perkin-Elmer 1600 FT IR spectrometer with absorbances quoted as ν in cm -1 . NMR spectra were run in CDCl 3 (unless otherwise specified) on Brüker Avance 250, 300. 400 or 500 MHz 30 instruments at 298 K. Mass spectra were recorded with a micrOTOF electrospray time-of-flight (ESI-TOF) mass spectrometer (Brüker Daltonik). 35 This was performed in accordance with a literature procedure, 8 substituting meta-bromobenzoate for benzoate in the biotransformation step. A sterile pipette tip was streaked across the surface of a frozen glycerol stock solution of R. eutrophus B9 cells to produce small shards (approx. 10 mg). 40 The frozen shards were added to a sterile 250 mL Erlenmeyer flask containing 100 mL of Hutner's mineral base medium 8, 33 and aqueous sodium succinate solution (500 μL of a 1.5 M solution). The flask was shaken at 250 rpm for 48 h at 30 °C. The culture was then transferred to a 20 L plastic carboy and 45 additional medium was added to give a total volume of 15 L. Air was continuously sparged through the culture. Sodium succinate solution (50 mL) was added and the culture was incubated for 48 h. The temperature was maintained at 30 °C by means of immersed Nalgene ® 380 food grade tubing, 50 through which was passed heated water. Subsequently, sodium benzoate solution (5 mL of a 1.0 M solution) was added to initiate BZDO expression. After 3 h, sodium metabromobenzoate (50 mL of a 1.0 M solution) and sodium succinate (25 mL of a 1.5 M solution) were added. Over the 55 next 48 h, sodium meta-bromobenzoate solution (1.0 M) and sodium succinate solution (1.5 M) were added portionwise. In total 60.3g (270 mmol) sodium meta-bromobenzoate and 48.6g (300 mmol) sodium succinate were introduced. The culture was incubated for a further 72 h, then the fermentation 60 broth was centrifuged at 6000 rpm for 25 min and the supernatant liquid decanted. The supernatant was concentrated under reduced pressure (rotary evaporator bath temperature <40 °C) to a total volume of 1.5 L. The concentrated supernatant was then carefully acidified to pH 3.0 with 65 concentrated hydrochloric acid. The acidified solution was then extracted with ethyl acetate (20 × 1 L). After each two extractions, the aqueous phase was re-acidified to pH 3.0. Each organic extract was dried over MgSO 4 and filtered. Combined filtrates were concentrated under reduced pressure 70 to give 51.4 g of crude material, of which unreacted metabromobenzoic acid was the major constituent. This material was repeatedly triturated with copious quantities of dichloromethane, resulting in dissolution of most of the material. (Toluene was also determined to be a suitable 75 triturant.) After 7 such triturations and drying under vacuum, the residual solid material was shown by NMR to be pure (1S,6S)-5-bromo-1,6-dihydroxycyclohexa-2,4-dienecarboxylic acid 9, a brown powder; 979 mg (4.17 mmol), 1.5%, 65 mg dm -3 . 
Biotransformation of meta-bromobenzoic acid

(1S,6S)-Methyl 5-bromo-1,6-dihydroxycyclohexa-2,4-dienecarboxylate (11)
To a stirred solution of 9 (61 mg, 0.260 mmol, 1 equiv) in MeOH / benzene (1:1, 32 mL) at room temperature was added dropwise (trimethylsilyl)diazomethane (1.5 mL, 2.0 M in 95 hexanes) until the yellow colour persisted and effervescence ceased. The solution was stirred for 2 h then concentrated under reduced pressure to give crude (1S,6S)-methyl 5-bromo-1,6 dihydroxycyclohexa-2,4-diene carboxylate 11 (61 mg, 94 %) as a brown oil, sufficiently pure to be used without further ; v max (film) 3451, 2953, 1734, 1643, 1572, 1255, 1105, 1034, 940, 809 , 695 cm -1 ; HRMS (ESI+) m/z calcd for (C 8 H 9 BrO 4 +Na) + , 270.9582, 272.9561; found 270.9576, 272.9559 .   (3aS,7aS)-Methyl 7-bromo-2,2-dimethyl-3a,7a-dihydrobenzo-[d][1,3] dioxole-3a-carboxylate (12) 5 To diol 11 (84 mg, 0.337 mmol, 1 equiv) and paratoluenesulfonic acid (2.0 mg, 0.01 mmol, 0.03 equiv) in acetone (30 mL) was added 2,2-dimethoxypropane (600 μL, 4.88 mmol, 14.5 equiv) . The reaction mixture was stirred at room temperature for 48 h, transferred to a separating funnel, 10 washed with saturated NaCl (aq) then extracted with EtOAc. The organic phase was dried over MgSO 4 and filtered. The filtrate was concentrated under reduced pressure to give (3aS,7aS)-methyl 7-bromo-2,2-dimethyl-3a,7a-dihydrobenzo- ; v max (film) 2971, 1775, 1706, 1602, 1358, 1240, 1211, 1159, 1009, 957, 758, 723, 687 (3aS,4R,10R,10aS)-Methyl 10-bromo-2,2-dimethyl-6,8-dioxo-7-phenyl-4,6,7,8,10,10a-hexahydro-3aH-4,10-etheno[1,3 5-d][1,2,4]triazolo[1,2- 
a]pyridazine-3a-carboxylate 13
To a solution of diene 12 (49 mg, 0.17 mmol, 1 equiv) in acetone (4.0 mL) at room temperature was added in a dropwise fashion a solution of 4-phenyl-1,2,4-triazoline-3,5-35 dione in acetone, until a faint red colour of the dione persisted. After 1 h, the reaction mixture was concentrated under reduced pressure to give (3aS,4R,10R,10aS)-methyl 10bromo-2,2-dimethyl-6,8-dioxo-7-phenyl-4,6,7,8,10,10ahexahydro-3aH-4,10-etheno[1,3] dioxolo [4,5-d] 135.4, 130.7, 129.2, 128.8, 127.6, 125.8, 114.3 84.2, 82.9, 67.7, 53.9, 53.8, 26.2, 26.1; v max (film) 2993, 1786, 1721, 1559, 1501, 1457, 1400, 1260, 1214, 1149, 1088, 974, 880, 754 cm 4R,5R,7aS)-Methyl  7-bromo-4,5-dihydroxy-2,2dimethyl-3a,4,5,7a-tetrahydrobenzo[d][1,3 
]dioxole-3acarboxylate (14)
To a solution of 11 (14. 0 mg, 0.048 mmol, 1 equiv) and NMO 60 (6.6 mg, 0.048 mmol, 1 equiv) in acetone/H 2 O 4:1 (3 mL) was added OsO 4 (10 μL, 2.5 wt% in tBuOH, 2 mol%). The reaction mixture was stirred at room temperature for 24 h, then diluted with Na 2 S 2 O 3(aq) and extracted with EtOAc. The organic extracts were dried over MgSO 4 and filtered. The 65 filtrate was concentrated under reduced pressure and purified by column chromatography (40% EtOAc-petrol) to give (3aS,4R,5R,7aS)-methyl 7-bromo-4,5-dihydroxy-2,2-dimethyl-3a,4,5,7a-tetrahydrobenzo[d] [1, 3] dioxole-3a-carboxylate 14 (11 mg, 80%) as a colourless oil: R f 0.32 (40% EtOAc- ((3aR,7aS)-7-Bromo-2,2-dimethyl-3a,7a-dihydrobenzo-[d][1,3] dioxol-3a-yl)methanol 17 85 To ester 12 (68.9 mg, 0.235 mmol, 1 equiv) was added lithium aluminium hydride (9.0 mg, 0.237 mmol, 1 equiv) as a solution in diethyl ether (25 mL). The reaction mixture was stirred at room temperature for 1 h, then cooled to 0 °C. Excess EtOAc was added dropwise by syringe to quench 90 unreacted reductant, then the reaction mixture was cautiously added to a saturated aqueous solution of sodium potassium tartrate (Rochelle's salt). The reaction mixture was stirred vigorously for 1 h, then the phases were separated. The organic phase was dried over MgSO 4 then filtered. The filtrate 95 was concentrated under reduced pressure and purified by chromatography (30% EtOAc-petrol) to afford ((3aR,7aS) (17) ; v max (film) 3413, 2918, 2956, 2852, 1465, 1383, 1222, 1943, 750 -(3aS,7aS)-methyl 7-bromo-2,2-dimethyl-3a,7a-dihydrobenzo[d][1,3] To a flask containing 12 (185 mg, 0.59 mmol, 1 equiv) in a glovebox was added nonacarbonyldiiron (440 mg, 1.21 mmol, 2 equiv). THF (40 mL) was added and the reaction mixture 10 was stirred at room temperature for 7 d. The reaction mixture was then concentrated under reduced pressure (Care! Toxic pentacarbonyliron distilled over at this point) and purified by column chromatography (10% EtOAc-petrol) to give (4S)tricarbonyl(η 4 -(3aS,7aS)-methyl 7-bromo-2,2-dimethyl-3a,7a- ; v max (film) 2981, 2068, 2003, 30 1730, 1437, 1375, 1261, 1214, 1162, 1062, 1027, 978, 865, 752, 687, 636 cm -1 ; HRMS (ESI+) m/z calcd for (C 14 H 13 BrFeO 7 +Na) + , 450.9092, 452.9071; found 450.9106, 452.9164. Complex 22 ; v max (film) 2980, 2061, 1995, 1729, 1460, 1380, 1252, 1207, 1168, 1070, 1030 ; v max (film) 2973, 2937, 2888, 1741, 1469, 1381, 1308, 1163, 1131, 1105, 951, 821 (3aS,7aR)-Methyl 2,2-dimethyl-7-((triisopropylsilyl)ethynyl)-3a,7a-dihydrobenzo[d][1,3 
]dioxole-3a-carboxylate 25
To a solution of bromodiene 12 (81 mg, 0.28 mmol, 1 equiv), 85 tetrakis(triphenylphosphine)palladium (16 mg, 0.014 mmol, 5 mol %), copper(I) iodide (3.7 mg, 0.0196 mmol, 7 mol %) dissolved in THF (20 mL), was added by syringe nbutylamine (110 μL, 1.12 mmol, 4 equiv) and (triisopropyl)acetylene (100 μL, 0.45 mmol, 1.6 equiv). The 90 reaction mixture was stirred at room temperature for 24 h, then diluted with EtOAc and washed with NH 4 Cl (aq) and NaCl (aq) . The organic phase was dried over MgSO 4 and filtered. The filtrate was concentrated under reduced pressure and purified by column chromatography (10% EtOAc-petrol) 95 to give (3aS,7aR)-methyl 2,2-dimethyl-7-((triisopropylsilyl)ethynyl)-3a,7a-dihydrobenzo[d] [1, 3] dioxole-3acarboxylate (25) (108 mg, 98%) as a yellow oil: R f 0.45 (10% EtOAc-petrol); [α] D 25 -176º (c 0.89, CH 2 Cl 2 ); δ H (250 MHz) 6.37 (1H, d, J = 6.0 Hz, SiC≡C-C=CH), 6.12 (1H, dd, J = 9.5, ; v max (film) 2943, 2865, 2158, 2032, 1741, 1462, 1381, 1243, 1039, 883, 677 To a stirred solution of silylacetylene 25 (9.6 mg, 0.03 mmol, 1 equiv) in THF (30 mL) at room temperature was added tetra-n-butylammonium fluoride (1.0 M solution in THF, 0.05 mL, 0.05 mmol, 1.1 equiv). The reaction mixture was stirred for 24 h, then diluted with EtOAc and washed with NaCl (aq) . 5 The organic layer was dried over MgSO 4 and filtered. The filtrate was concentrated under reduced pressure and purified by column chromatography (15% EtOAc-petrol) to give (3aS,7aR)-methyl 7-ethynyl-2,2-dimethyl-3a,7a-dihydrobenzo[d] [1, 3] dioxole-3a-carboxylate (26) To a stirred solution of terminal alkyne 26 (13.0 mg, 0.05 mmol, 1 equiv) in EtOH/H 2 O 5:1 (25 mL) were added benzyl azide (7.9 mg, 0.06 mmol, 1.2 equiv), CuSO 4 (1.1 mg, 1 mol 30 %) and ascorbic acid (5.9 mg, 10 mol%). The solution was stirred at room temperature for 48 h, then diluted with NaCl (aq) and extracted with EtOAc. The organic layer was dried over MgSO 4 and filtered. The filtrate was concentrated under reduced pressure and purified by column chromatography 35 (10% to 50% EtOAc-petrol) to give unreacted 26 (7.8 mg, 66%) and ( 8, 129.3, 128.8, 128.1, 127.8, 126.1, 124.9, 124.5, 121 ; v max 50 (film) 2995, 2917, 1857, 1739, 1496, 1457, 1258, 1066, 887, 799, 727 
